Corient Private Wealth LLC lessened its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 4.0% during the ...

Investors in CRISPR Therapeutics AG (Symbol: CRSP) saw new options begin trading this week, for the May 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

Samarth Kulkarni, the Chief Executive Officer of $CRSP, sold 10,031 shares of the company on 03-21-2025 for an estimated $413,578. We received data on the trade from ...

CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

Congress Wealth Management LLC DE purchased a new stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) in the 4th ...

Investors in CRISPR Therapeutics AG (Symbol: CRSP) saw new options begin trading today, for the April 25th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

Investors in CRISPR Therapeutics AG (Symbol: CRSP) saw new options become available today, for the May 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

Shares of CRISPR Therapeutics CRSP closed at $40.97 on Tuesday, close to their 52-week low of $36.52. This decline in CRSP stock is mainly due to a lack of pipeline updates, which is not sitting ...

CRISPR Therapeutics AG (CRSP) closed the latest trading day at ... and the technology-centric Nasdaq increased by 0.52%. The company's stock has dropped by 18.36% in the past month, falling ...

A month has gone by since the last earnings report for CRISPR Therapeutics AG (CRSP). Shares have added about 0.4% in that time frame, outperforming the S&P 500. Will the recent positive trend ...

Among them are CRISPR Therapeutics (NASDAQ: CRSP) and Merck (NYSE: MRK), two companies that develop innovative medical therapies. CRISPR Therapeutics' shares are down by 41% over the trailing-12 ...

The latest trading session saw CRISPR Therapeutics AG (CRSP) ending at $41.17 ... while the tech-heavy Nasdaq depreciated by 0.33%. The company's shares have seen a decrease of 20.9% over the ...